Bridgewest Perth Pharma Pty Ltd, parent company of CDMO NovaCina, is pleased to announce that it has been selected as a recipient of the Investment Attraction Fund by the Western Australian government. As a recipient of this fund, Bridgewest Perth Pharma will receive financial support that will be instrumental in expanding its operations within Western Australia, ensuring the integral preservation of local pharmaceutical manufacturing and job opportunities.
“Through the Investment Attraction Fund, we’re driving a strong and diversified economy that delivers secure, quality jobs for the future.” – Premier Roger Cook.